This is the strongest insider buy signal possible — a C-suite and board cluster at 2.2% of market cap. Traders should expect a significant positive re-rating as the market digests this signal. Monitor for an imminent press release or catalyst (e.g., clinical data, partnership, or M&A) that the insiders may be anticipating. The $18.00 level now serves as a strong floor.
Price Chart
Executive Summary
A massive insider buying cluster at Braveheart Bio (BRVE) saw 8 insiders, including the CEO, CFO, and two major 10% owners, purchase a total of $44.1M in open-market shares at $18.00 on August 7, 2026. This is a highly unusual and concentrated vote of confidence from the highest levels of the company, representing approximately 2.2% of the company's $2.0B market cap. The cluster is amplified by the simultaneous conversion of derivatives by major holders, signaling a strong alignment with common equity and a bullish outlook on upcoming catalysts.
Key Financial Metrics
Key Facts
- 8 insiders purchased $44.1M in open-market shares on a single day (Aug 7, 2026).
- CEO Travis Murdoch and CFO James Paul Rickey both made open-market purchases.
- Two 10% owners (AH Bio Fund IV and Forbion Growth) purchased a combined $54.4M and converted large derivative positions.
- Total open-market purchases represent ~2.2% of BRVE's $2.0B market cap, well above the >2% materiality threshold.
- All purchases were at the same $18.00 price, suggesting a coordinated or highly aligned transaction.
Financial Impact
$44.1M in open-market insider purchases, representing ~2.2% of market cap
Risk Factors
- Insiders may be buying to support the stock price ahead of a dilutive offering, though the size and seniority make this unlikely.
- If no catalyst materializes within 4-6 weeks, the signal may be partially discounted.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BRVE-1786485690629 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 3 | $27.66 $26.71 | ▼ −3.43% | ▼ −1.46% | $21.87 (−20.93%) |
Aug 11, 2026 10w ago | Insider Cluster | $26.15 $27.25 | ▲ +4.21% | ▲ +6.10% | $21.87 (−16.37%) |
Aug 11, 2026 10w ago | Insider Cluster | $26.15 $27.25 | ▲ +4.21% | ▲ +6.10% | $21.87 (−16.37%) |
Aug 7, 2026 11w ago | Insider Cluster | $27.53 $29.41 | ▲ +6.83% | ▲ +7.74% | $21.87 (−20.56%) |
Aug 7, 2026 11w ago | Insider Cluster | $27.53 $29.41 | ▲ +6.83% | ▲ +7.74% | $21.87 (−20.56%) |
Aug 5, 2026 11w ago | Press Release | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.87 (−26.61%) |
Aug 5, 2026 11w ago | 3 | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.87 (−26.61%) |
Aug 5, 2026 11w ago | 3 | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.87 (−26.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers